FYI - For Your Innovation

Ozempic, AI Wearables, Tesla Price Cuts | The Brainstorm EP 18

9 snips
Oct 13, 2023
This podcast discusses the weight loss properties of GLP1s and their impact on healthcare spending. It explores the potential risks and drawbacks of the weight loss drug Ozempic. The hosts also talk about AI companions, AI hardware, and challenges of monetization. They highlight the importance of brand trust and storytelling in wearables adoption. Finally, they analyze Tesla's recent price cuts and their implications.
Ask episode
Chapters
Transcript
Episode notes